Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
712.3 EUR | -1.40% | +4.37% | +35.29% |
May. 10 | Cipla Open to Partner With Eli Lilly to Market Obesity Drugs in India | MT |
May. 10 | Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows | RE |
Sales 2024 * | 42.81B 39.76B | Sales 2025 * | 52.47B 48.73B | Capitalization | 684B 636B |
---|---|---|---|---|---|
Net income 2024 * | 11.93B 11.08B | Net income 2025 * | 16.55B 15.37B | EV / Sales 2024 * | 16.5 x |
Net Debt 2024 * | 19.98B 18.56B | Net Debt 2025 * | 15.29B 14.2B | EV / Sales 2025 * | 13.3 x |
P/E ratio 2024 * |
56.8
x | P/E ratio 2025 * |
40.9
x | Employees | 43,000 |
Yield 2024 * |
0.68% | Yield 2025 * |
0.79% | Free-Float | 99.8% |
Latest transcript on Eli Lilly and Company
1 day | -1.40% | ||
1 week | +4.37% | ||
Current month | -2.01% | ||
1 month | +0.68% | ||
3 months | +4.75% | ||
6 months | +27.88% | ||
Current year | +35.29% |
Managers | Title | Age | Since |
---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 56 | 95-12-31 |
Anat Ashkenazi
DFI | Director of Finance/CFO | 51 | 00-12-31 |
Ruth Gimeno
PSD | President | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 21-01-24 | |
Ralph Alvarez
BRD | Director/Board Member | 68 | 09-03-31 |
Jon Fyrwald
BRD | Director/Board Member | 63 | 04-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 712.3 | -1.40% | 324 |
24-05-09 | 722.4 | +0.12% | 38 |
24-05-08 | 721.5 | -0.19% | 366 |
24-05-07 | 722.9 | +1.76% | 567 |
24-05-06 | 710.4 | +4.09% | 415 |
Delayed Quote Deutsche Boerse AG, May 10, 2024 at 10:30 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B | |
-2.71% | 159B |
- Stock Market
- Equities
- LLY Stock
- LLY Stock